about
Traditional medicines and globalization: current and future perspectives in ethnopharmacologyCurcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st centuryCurcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelatorCurcumin AntiCancer Studies in Pancreatic CancerNovel delivery system for natural products: Nano-curcumin formulationsCurcumin and Resveratrol as Promising Natural Remedies with Nanomedicine Approach for the Effective Treatment of Triple Negative Breast CancerThe Potential of Curcumin in Treatment of Spinal Cord InjurySulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician's Expectation Be Matched by the Reality?Marine Diterpenoids as Potential Anti-Inflammatory AgentsCurcumin and Apigenin - novel and promising therapeutics against chronic neuroinflammation in Alzheimer's diseaseCurcumin and tumor immune-editing: resurrecting the immune systemPhytochemicals as Innovative Therapeutic Tools against Cancer Stem CellsCurcumin as a therapeutic agent in dementia: a mini systematic review of human studiesCurcumin slows osteoarthritis progression and relieves osteoarthritis-associated pain symptoms in a post-traumatic osteoarthritis mouse modelTherapeutic Potential of Curcumin for the Treatment of Brain TumorsUnraveling the Anticancer Effect of Curcumin and ResveratrolA multi-targeted approach to suppress tumor-promoting inflammationCurcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatmentCurcumin significantly enhances dual PI3K/Akt and mTOR inhibitor NVP-BEZ235-induced apoptosis in human renal carcinoma Caki cells through down-regulation of p53-dependent Bcl-2 expression and inhibition of Mcl-1 protein stabilityThe Essential Medicinal Chemistry of CurcuminPolymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy.A classification model to predict synergism/antagonism of cytotoxic mixtures using protein-drug docking scoresChemopreventive potential of curcumin in prostate cancerCerium oxide nanoparticles in cancerInhibitory effect of epigallocatechin gallate (EGCG), resveratrol, and curcumin on proliferation of human retinal pigment epithelial cells in vitro.Maternal obesity, inflammation, and developmental programming.Phase I dose-escalation trial of intravaginal curcumin in women for cervical dysplasia.Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injuryCurcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.Therapeutic applications of curcumin for patients with pancreatic cancer.Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial.N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin.Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia.Pharmacokinetics of curcumin conjugate metabolites in healthy human subjectsCurcumin mediated suppression of nuclear factor-κB promotes chondrogenic differentiation of mesenchymal stem cells in a high-density co-culture microenvironment.Epigenetic changes induced by curcumin and other natural compounds.Management of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-term follow-up.Controlled-release systemic delivery - a new concept in cancer chemoprevention.Cyclooxygenase-1 and -2: molecular targets for cervical neoplasia.Curcumin Inhibits STAT3 Signaling in the Colon of Dextran Sulfate Sodium-treated Mice.
P2860
Q21129278-B86F8873-6B30-489D-8015-1EE57E391ABEQ24630927-9B49819A-AE09-4FFE-B431-2D05F35C6AAAQ24652363-FB99ECF4-A97E-438C-B7EC-3668CAE1BDA5Q26738714-1AD1257E-5671-49C6-8DF7-D31CEEF551E8Q26741732-82935BA9-BE83-47B2-A546-AA3E4708C1D3Q26744566-E348F57E-3D8F-4B54-982A-CE087D4F96B7Q26746153-F0B377C5-867C-45B7-BED8-5E1709103AF9Q26765790-6DE6FEB5-6142-4810-BF39-32F42548958AQ26779952-9BF4FD23-FF7C-4A67-AFF2-87AF76A7390AQ26781090-ADD9C543-299E-4E2B-9F99-9DBAFE17177EQ26783491-27844AE7-51A4-42B4-831B-DAA521CB1951Q26799995-600A1295-916C-4BE8-A2C2-260C7B118ABBQ27012755-4AEBA46F-D9E7-4E54-9D4F-F408CA26A6EFQ27325703-908410BB-996C-4CE5-B5F1-57695FBF7FBAQ28071572-F2B40B53-0561-4768-A2C3-70D454638277Q28073155-2773CD17-CBEA-4566-B454-66687F94F144Q28393278-5BFB17EB-E2F9-40EE-B76D-838386E7F36EQ28393316-5DEB54B0-C4E7-4320-A598-BE62F95FB574Q28538024-0AAA999E-3077-45A9-8460-8831EB7AFC1AQ30841584-098861D2-0AA7-4EDB-B59A-3450DCCC3CFBQ33282319-518085E8-AC14-4394-BA55-985B04514FC4Q33355830-27F2C8BD-6451-4AE3-88A0-28E5DF25B358Q33646014-42F8B450-E60A-4D7A-BD10-D0723C85C343Q33706871-6D30BF48-D0A3-4621-8A21-B8003C802593Q33722456-8A9713E7-ABC3-47AE-843B-1622FCDBF05EQ33747395-2C4DA31B-F339-4F10-B6A3-334BD372C489Q33764245-4B929442-339D-449C-9ACE-E15FCC0C38DCQ33840489-28F0AB65-72E8-4A36-994B-7C395E074F60Q33906004-538B6876-E60D-488D-9C29-D4B619BFBCACQ33948351-7F16DF51-C2ED-4E7D-B302-34D7020893DDQ34038554-F9129F01-AB03-4663-8F28-438CFE61194FQ34050685-05AD069B-F244-44AB-B59E-D9FEC075FCCAQ34060487-7468E601-5636-44DB-94AE-63FFAA9E1828Q34069410-09F66F48-1263-49D1-9379-24726F94B7D1Q34152916-B8B29AF7-4D64-4F69-B3FB-8DC3835B94B5Q34180255-5340E16F-6040-4C2F-AE62-54637F08F9DFQ34245258-490F7204-501C-44CC-A716-EDDA241FAC27Q34281406-42BA5903-ABE2-4028-ABFD-0916786EBD88Q34305332-ECDA5053-3F61-4674-AC4C-E3266771EC6BQ34305357-91747CC0-AB19-46F4-9ACC-F86147F97086
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Dose escalation of a curcuminoid formulation
@ast
Dose escalation of a curcuminoid formulation
@en
type
label
Dose escalation of a curcuminoid formulation
@ast
Dose escalation of a curcuminoid formulation
@en
prefLabel
Dose escalation of a curcuminoid formulation
@ast
Dose escalation of a curcuminoid formulation
@en
P2093
P2860
P356
P1476
Dose escalation of a curcuminoid formulation
@en
P2093
Cheryl L Rock
Christopher D Lao
Dean E Brenner
Dennis D Heath
James Crowell
Joanne M Bailey
Martha E Boggs
Sandra I Murray
P2860
P2888
P356
10.1186/1472-6882-6-10
P577
2006-03-17T00:00:00Z
P5875
P6179
1045578930